Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Other Accumulated Expenses (2019 - 2025)

Qiagen's Other Accumulated Expenses history spans 11 years, with the latest figure at $73.4 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 11.26% to $73.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $73.4 million, a 11.26% decrease, with the full-year FY2025 number at $73.4 million, down 11.26% from a year prior.
  • Other Accumulated Expenses hit $73.4 million in Q4 2025 for Qiagen, down from $82.7 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for QGEN hit a ceiling of $82.7 million in Q4 2024 and a floor of $59.2 million in Q4 2022.
  • Historically, Other Accumulated Expenses has averaged $68.9 million across 5 years, with a median of $66.6 million in 2021.
  • Biggest five-year swings in Other Accumulated Expenses: soared 31.6% in 2024 and later dropped 11.26% in 2025.
  • Tracing QGEN's Other Accumulated Expenses over 5 years: stood at $66.6 million in 2021, then decreased by 11.12% to $59.2 million in 2022, then grew by 6.14% to $62.8 million in 2023, then surged by 31.6% to $82.7 million in 2024, then dropped by 11.26% to $73.4 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for QGEN at $73.4 million in Q4 2025, $82.7 million in Q4 2024, and $62.8 million in Q4 2023.